Sodium-glucose cotransporter-2 inhibitors, severe sepsis, and infection-related outcomes in patients with chronic kidney disease and type 2 diabetes.
- DOI
- 10.23876/j.krcp.26.134
- Published
- 2026-09-09
- Container
- Kidney Res Clin Pract
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.23876/j.krcp.26.134,
title = {Sodium-glucose cotransporter-2 inhibitors, severe sepsis, and infection-related outcomes in patients with chronic kidney disease and type 2 diabetes.},
author = {Wang CA and Wang WJ and Chen JY and Tseng YH and Cheng CY and Wu VC.},
year = {2026},
journal = {Kidney Res Clin Pract},
doi = {10.23876/j.krcp.26.134},
url = {https://doi.org/10.23876/j.krcp.26.134}
}RIS
TY - JOUR TI - Sodium-glucose cotransporter-2 inhibitors, severe sepsis, and infection-related outcomes in patients with chronic kidney disease and type 2 diabetes. AU - Wang CA AU - Wang WJ AU - Chen JY AU - Tseng YH AU - Cheng CY AU - Wu VC. PY - 2026 JO - Kidney Res Clin Pract DO - 10.23876/j.krcp.26.134 UR - https://doi.org/10.23876/j.krcp.26.134 ER -
APA
CA, W., WJ, W., JY, C., YH, T., CY, C., & VC., W. (2026). Sodium-glucose cotransporter-2 inhibitors, severe sepsis, and infection-related outcomes in patients with chronic kidney disease and type 2 diabetes.. Kidney Res Clin Pract. https://doi.org/10.23876/j.krcp.26.134
Source records
- europe-pmc · retrieved 2026-09-26T20:20:43.068Z